XML 48 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating Activities    
Net income $ 9,822 $ 7,140
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 2,808 3,191
Amortization of bond premiums 216 127
Provision for losses on accounts receivable, net of adjustments (130) 269
Provision for excess and obsolete inventories, net 4 169
Share-based compensation 412 392
Excess tax benefits from stock options exercised and restricted stock awards vested (356) (109)
(Gain) loss on disposal of assets (24) 7
Foreign currency transaction gain 31 19
Interest income on note receivable (10) (10)
Deferred income taxes (1,154) (1,205)
Changes in assets and liabilities:    
Accounts receivable (6,511) 5,046
Income tax receivable 1,429 (172)
Inventories (2,755) (1,541)
Prepaid expenses and other (397) (99)
Accounts payable 3,441 (1,838)
Deferred revenue 204 0
Accrued liabilities 2,039 (2,895)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9,069 8,491
Investing Activities    
Capital expenditures (3,616) (997)
Proceeds from sale of property, plant and equipment 27 0
Investment in certificates of deposits 0 (238)
Maturities of certificates of deposits 1,403 720
Purchase of investments held to maturity 0 (1,396)
Maturities of investments 2,717 610
Proceeds from called investment 253 0
Principal payments from note receivable 17 20
Net cash provided by (used in) investing activities 801 (1,281)
Financing Activities    
Borrowings under revolving credit facility 0 1,955
Payments under revolving credit facility 0 (1,955)
Stock options exercised 340 354
Excess tax benefits from stock options exercised and restricted stock awards vested 356 109
Repurchase of stock (2,981) (1,115)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations (2,285) (652)
Net increase in cash and cash equivalents 7,585 6,558
Cash and cash equivalents, beginning of period 12,085 3,159
Cash and cash equivalents, end of period $ 19,670 $ 9,717